Radiotherapy utilization in developing countries: An IAEA study

Publication date: Available online 30 May 2018
Source:Radiotherapy and Oncology
Author(s): Eduardo Rosenblatt, Elena Fidarova, Eduardo H. Zubizarreta, Michael B. Barton, Glenn W. Jones, William J. Mackillop, Lisbeth Cordero, Joel Yarney, Gerard Lim, John V. Gan, Valentin Cernea, Suzana Stojanovic-Rundic, Primoz Strojan, Lotfi Kochbati, Aldo Quarneti
BackgroundThe planning of national radiotherapy (RT) services requires a thorough knowledge of the country's cancer epidemiology profile, the radiotherapy utilization (RTU) rates and a future projection of these data. Previous studies have established RTU rates in high-income countries.MethodsOptimal RTU (oRTU) rates were determined for nine middle-income countries, following the epidemiological evidence-based method. The actual RTU (aRTU) rates were calculated dividing the total number of new notifiable cancer patients treated with radiotherapy in 2012 by the total number of cancer patients diagnosed in the same year in each country. An analysis of the characteristics of patients and treatments in a series of 300 consecutive radiotherapy patients shed light on the particular patient and treatments profile in the participating countries.ResultsThe median oRTU rate for the group of nine countries was 52% (47–56%). The median aRTU rate for the nine countries was 28% (9–46%). These results show that the real proportion of cancer patients receiving RT is lower than the optimal RTU with a rate difference between 10–42.7%. The median percent-unmet need was 47% (18–82.3%).ConclusionsThe optimal RTU rate in middle-income countries did not differ significantly from that previously found in high-income countries. The actual RTU rates were consistently lower than the optimal, in particular in countries with limited resources and a large population.



https://ift.tt/2spCPDm